Award

Delivery Order #SPE2DR26F9S8F

Delivery Order for Novolog Insulin Pens to AmerisourceBergen

Buyer

Defense Logistics Agency

Award Amount

$4,741.24

Ceiling

$4,741.24

Awarded

March 09, 2026

Period of Performance

Mar 09, 2026 – Mar 10, 2026

Identifier

SPE2DR26F9S8F

NAICS

424210

This award represents a delivery order contract issued under an existing indefinite delivery vehicle held by AmerisourceBergen Drug Corp, a leading pharmaceutical sourcing and distribution company serving health systems and pharmaceutical clients. The contract procures a specified quantity of Novolog 100 unit/ml FlexPen 3ml insulin pens, a crucial pharmaceutical product used in managing diabetes, thus supporting essential healthcare delivery. The scope of work includes the timely provision and delivery of these insulin pens to the designated location in Conshohocken, Pennsylvania, within a short window of performance. This order is part of a broader pharmaceutical supply agreement, demonstrating AmerisourceBergen's ongoing commitment and significant role in ensuring the continuous availability of vital medications to government health services. The contract was awarded as a follow-on delivery order to a parent indefinite delivery contract, indicating a non-competitive procurement consistent with previously established terms and vendor selection. The short-term timeline highlights the immediate procurement needs addressed by this contract to maintain uninterrupted patient care.

Description

4571087296!NOVOLOG 100 UNIT/ML FLEXPEN 3ML

View original record